Theravance Biopharma, Inc.
TBPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583107
In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Theravance Biopharma, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 109
- +2 vs. Q1 2021
- Shares held
- 60.8M
- +7.24M (+13.5%) vs. Q1 2021
- Total value
- $883.1M
- −$209.6M (−19.2%) vs. Q1 2021
- New holders
- 20
- 42 more added
- Sold out
- 18
- 26 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TBPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 179 | $817.5M |
| Q1 2026 | 173 | $814.2M |
| Q4 2025 | 169 | $927.2M |
| Q3 2025 | 161 | $706.3M |
| Q2 2025 | 135 | $512.2M |
| Q1 2025 | 132 | $400.9M |
| Q4 2024 | 128 | $422.4M |
| Q3 2024 | 119 | $368.9M |
| Q2 2024 | 132 | $399.5M |
| Q1 2024 | 121 | $430.6M |
| Q4 2023 | 118 | $548.7M |
| Q3 2023 | 115 | $438.5M |
| Q2 2023 | 119 | $546.3M |
| Q1 2023 | 114 | $652.6M |
| Q4 2022 | 119 | $696.1M |
| Q3 2022 | 123 | $649.8M |
| Q2 2022 | 113 | $582.0M |
| Q1 2022 | 121 | $602.5M |
| Q4 2021 | 116 | $655.6M |
| Q3 2021 | 119 | $448.8M |
| Q2 2021 | 109 | $883.1M |
| Q1 2021 | 107 | $1.09B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Theravance Biopharma, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 1,256,058 | $18.2M | 0.00% | +103,439+9.0% | Added |
| Chescapmanager LLC | 1,261,718 | $18.3M | 2.79% | +127,000+11.2% | Added |
| Maven Securities LTD | 1,342,574 | $20.1M | 2.12% | +1,342,574 | New |
| BlackRock Inc. | 4,520,707 | $65.6M | 0.00% | −113,428−2.4% | Reduced |
| OrbiMed Advisors LLC | 4,564,045 | $66.3M | 0.68% | −1,655,065−26.6% | Reduced |
| Vanguard Group Inc | 5,278,969 | $76.7M | 0.00% | +763,854+16.9% | Added |
| Wellington Management Group LLP | 8,727,324 | $126.7M | 0.02% | +1,263,122+16.9% | Added |
| Baupost Group LLCSuperinvestorBaupost Group | 9,910,168 | $143.9M | 1.17% | +1,175,000+13.5% | Added |
| FMR LLC | 10,791,863 | $156.7M | 0.01% | +1,061,697+10.9% | Added |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −93,700−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −56,014−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −40,962−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −30,564−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −29,800−100.0% | Sold out |
| Tocqueville Asset Management L.P. | 0 | $0 | 0.00% | −27,500−100.0% | Sold out |
| Old West Investment Management, LLC | 0 | $0 | 0.00% | −17,592−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −14,500−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −14,192−100.0% | Sold out |
| SG3 Management, LLC | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −12,414−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −10,412−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −3,800−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −1,603−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Jacobi Capital Management LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −239−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −92−100.0% | Sold out |